HomeCompareCIPMX vs JNJ

CIPMX vs JNJ: Dividend Comparison 2026

CIPMX yields 20.48% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIPMX wins by $55.2K in total portfolio value
10 years
CIPMX
CIPMX
● Live price
20.48%
Share price
$17.44
Annual div
$3.57
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$75.2K
Annual income
$7,088.67
Full CIPMX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CIPMX vs JNJ

📍 CIPMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIPMXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIPMX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIPMX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIPMX
Annual income on $10K today (after 15% tax)
$1,740.55/yr
After 10yr DRIP, annual income (after tax)
$6,025.37/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CIPMX beats the other by $5,321.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIPMX + JNJ for your $10,000?

CIPMX: 50%JNJ: 50%
100% JNJ50/50100% CIPMX
Portfolio after 10yr
$47.6K
Annual income
$3,958.23/yr
Blended yield
8.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CIPMX
No analyst data
Altman Z
208.5
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIPMX buys
0
JNJ buys
0
No recent congressional trades found for CIPMX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIPMXJNJ
Forward yield20.48%3.36%
Annual dividend / share$3.57$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$75.2K$20.0K
Annual income after 10y$7,088.67$827.78
Total dividends collected$43.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIPMX vs JNJ ($10,000, DRIP)

YearCIPMX PortfolioCIPMX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,748$2,047.71$10,676$355.77+$2.1KCIPMX
2$16,080$2,439.59$11,407$389.39+$4.7KCIPMX
3$20,081$2,875.92$12,198$426.53+$7.9KCIPMX
4$24,843$3,356.64$13,056$467.62+$11.8KCIPMX
5$30,463$3,881.01$13,987$513.12+$16.5KCIPMX
6$37,044$4,447.63$14,998$563.56+$22.0KCIPMX
7$44,691$5,054.49$16,098$619.52+$28.6KCIPMX
8$53,519$5,699.05$17,295$681.69+$36.2KCIPMX
9$63,643$6,378.25$18,599$750.82+$45.0KCIPMX
10$75,187$7,088.67$20,022$827.78+$55.2KCIPMX

CIPMX vs JNJ: Complete Analysis 2026

CIPMXStock

The investment seeks capital appreciation. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in securities of medium-sized companies. It seeks capital appreciation by investing mainly in common stocks of medium-sized companies that the Adviser believes have strong long-term fundamentals, superior capital appreciation potential and attractive valuations.

Full CIPMX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CIPMX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIPMX vs SCHDCIPMX vs JEPICIPMX vs OCIPMX vs KOCIPMX vs MAINCIPMX vs ABBVCIPMX vs MRKCIPMX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.